Zura Bio Ltd

Zura Bio Ltd is a clinical-stage biopharmaceutical company focused on immunology and immune-mediated diseases that filed an S-1 registration statement with the SEC on May 24, 2024, under accession number 0001410578-24-000964. The company, registered under CIK 0001855644, operates in the biotechnology and healthcare sector and entered the public markets through a SPAC-related transaction. The May 2024 S-1 represents a post-transaction registration filing, a standard step for companies that completed de-SPAC combinations and are registering shares for resale or follow-on activity. For full filing history, SPAC transaction details, and company-level analytics on Zura Bio and thousands of other de-SPAC entities, sign up for a SpacDesk account at spacdesk.com.